BiondVax Announces FDA Acceptance of IND Application for its Investigational Universal Flu Vaccine

– – Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, announced that its Investigational New Drug Application (IND) for its Multimeric-001 vaccine (M-001), More...